Abstract
There have been numerous recent advances in the management of glaucoma, not least the development of new drugs to help manage raised intraocular pressure. In addition, the concepts of improving blood flow to the optic nerve head and neuroprotection are currently provoking considerable interest. This article considers the aims and philosophy of glaucoma drug therapy, summarises some of the basic facts and principles of modem glaucoma medications, and suggests a practical approach to the choice of therapy.
Article PDF
References
Sommer A . Intraocular pressure and glaucoma. Am J Ophthalmol 1989;107:186–8
Anderson DR . Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture. Am J Ophthalmol 1989;108:485–95
Jay JL, Allan D . The benefit of early trabeculectomy versus conventional medicine in primary open angle glaucoma relative to severity of disease. Eye 1989;3:528–35
Migdal C, Gregory W, Hitchings R . Long term functional outcome of early surgery compared with laser and medicine in open angle glaucoma. Ophthalmology 1994;101:1651–7
Kobelt G . Health economics: an introduction to economic evaluation. London: Office of Health Economics, 1996.
Garratt S, editor. Primary open angle glaucoma: preferred practice plan. San Francisco: American Academy of Ophthalmology, 1989.
Kaufman PL, Mittag TW . Medical therapy of glaucoma. In: Posdos SM, Yanoff M, editors. Textbook of ophthalmology, vol 7, Glaucoma. London: Mosby, 1994.
Coakes RL, Brubaker RS . The mechanism of timolol in lower intraocular pressure. Arch Ophthalmol 1978;96:2045–8
Levobunolol Study Group. Levobunolol: a beta adrenoreceptor antagonist effective in the long term treatment of glaucoma. Ophthalmology 1985;92:1271–6
Searle JB, Lustgarten JS, Podos SM . A clinical trial of metipranolol, a non-cardioselective beta adrenergic antagonist in ocular hypertension. Am J Ophthalmol 1991;112:302–7
Berry DP, Van Buskirk EM, Shields MB . Betaxolol and timolol: a comparison of efficacy and side effects. Arch Ophthalmol 1984;102:43–5
Van Buskirk EM, Fraunfelder FJ . Ocular beta-blockers and systemic effects. Am J Ophthalmol 1984;98:623.
Wang RF, Searle JB, Rodos SM, Sugrue MF . MK-507 (L-671, 152): a topically active carbonic anhydrase inhibitor reduces aqueous humor production in monkeys. Arch Ophthalmol 1991;109:1297.
Lippa EA, Carben LE, Elinger B, et al . Dose-response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992;100:495.
Strahlman ER, Tipping R, Vogel R . A double-masked randomised 1 year study comparing dorzolamide (Trusopt), timolol and betaxolol. Arch Ophthalmol 1995;113:1009–16
Clineschmidt CM, Williams RD, Snyder E, Adamsons A . The Dorzolamide-Timolol Combination Study Group. A randomised trial in patients inadequately controlled with timolol alone, comparing the dorzolamide-timolol combination to monotherapy with timolol alone. Ophthalmology 1998;105:1952–9
Strahlman ER, Vogel R, Tipping R, Clineschmidt CM . The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. Ophthalmology 1996;103:1283–93
Toris CB, Yablonski ME, Camras CB, Brubaker RF . Mechanisms of ocular hypertensive effect of latanoprost and the maintenance of normal blood-aqueous barrier function. Surv Ophthalmol 1997;41 (Suppl 2):569–75.
Bill A . Uveoscleral drainage of aqueous humor: physiology and pharmacology. Prog Clin BioI Res 1989;312:417–27
Kaufman PL, Crawford K . Aqueous humor dynamics: how PGF2a lowers intraocular pressure. Prog Clin Biol Res 1989;312:387–416
Aim A, Stjernschantz J . Scandinavian Latanoprost Study Group. Effects on lOP and side effects of 0.005% latanoprost OD, evening and morning: a comparison with timolol. Ophthalmology 1995;102:1734–52
Watson P, Stjernschantz J . Latanoprost Study Group. A six month randomised double-masked study comparing latanoprost to timolol in open angle glaucoma and ocular hypertension. Ophthalmology 1996;103:126–37
Camras CB . United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six month masked, multicenter trial in the US. Ophthalmology 1996;103:138–47
Alm A, Wiodengard I, Kjellgren D, et al . Latanoprost administered once daily caused a maintained reduction of lOP in glaucoma patient treated concomitantly with timolol. Br J Ophthalmol 1995;79:12–16
Pulo AH, Greve EL, Hoyng PF . Additive effect of latanoprost, a prostaglandin PGF2 analogue, and timolol in patients with elevated intraocular pressure. Br J Ophthalmol 1994;78:899–902
Selen G, Stjernschantz J, Resul B . Prostaglandin-induced pigmentation in primates. Surv Ophthalmol 1997;41 (Suppl 2):S125–8.
Toris CB, Gleason ML, Camras CB, Yablonski ME . Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol 1995;113:1514–7
Schuman JS . Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Surv Ophthalmol 1996;41 (Suppl 1):S27–37.
Searle JB . Brimonidine Study Group III. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated IOP. Surv Ophthalmol 1996;41 (Suppl 1):539–47.
Lachkar Y, Migdal C, Dhanjil S . Effect of brimonidine tartrate on ocular hemodynamic measurements. Arch Ophthalmol 1998;116:1591–4
March WF, Stewart RM, Mandell AI, Bruce LA . Duration of effect of pilocarpine gel. Arch Ophthalmol 1982;100:1270.
Quigley HA, Pollack IP, Harbin TS Jr . Pilocarpine Ocuserts: longterm clinical trials and selected pharmacodynamics. Arch Ophthalmol 1975;93:771.
Clineschmidt CM, Strahlman ER, Anderson K . Timolol/MK507: comparison of a fixed combination of dorzolamide and timolol (b.i.d.) to concomitant administration of dorzolamide (t.i.d.) plus timolol (b.i.d.) in patients with open angle glaucoma for three months. Invest Ophthalmol Vis Sci 1995;36 (Suppl):3405.
European Glaucoma Society. Terminology and guidelines for glaucoma. Savona: Dogma, 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Migdal, C. Glaucoma medical treatment: Philosophy, principles and practice. Eye 14, 515–518 (2000). https://doi.org/10.1038/eye.2000.138
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.138
Keywords
This article is cited by
-
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Nature Reviews Drug Discovery (2012)
-
Production of imidazole alkaloids in cell cultures of jaborandi as affected by the medium pH
Biotechnology Letters (2009)